Optimization of β-carotene loaded solid lipid nanoparticles preparation using a high shear homogenization technique
Source abstract
Abstract
Using statistical experimental design methodologies, the solid lipid nanoparticle design space was found to be more robust than previously shown in literature. Formulation and high shear homogenization process effects on solid lipid nanoparticle size distribution, stability, drug loading, and drug release have been investigated. Experimentation indicated stearic acid as the optimal lipid, sodium taurocholate as the optimal cosurfactant, an optimum lecithin to sodium taurocholate ratio of 3:1, and an inverse relationship between mixing time and speed and nanoparticle size and polydispersity. Having defined the base solid lipid nanoparticle system, β-carotene was incorporated into stearic acid nanoparticles to investigate the effects of introducing a drug into the base solid lipid nanoparticle system. The presence of β-carotene produced a significant effect on the optimal formulation and process conditions, but the design space was found to be robust enough to accommodate the drug. β-Carotene entrapment efficiency averaged 40%. β-Carotene was retained in the nanoparticles for 1 month. As demonstrated herein, solid lipid nanoparticle technology can be sufficiently robust from a design standpoint to become commercially viable.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Surfactants and Colloidal Systems · Lipid Membrane Structure and Behavior
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (16)
Show source-provided references
1. Ahlin P, Kristl J, Smid-Korbar J (1998) Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions. Acta Pharm 48:259–267
2. Bocca C, Caputo O, Cavalli R et al (1998) Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles. Int J Pharm 175:185–19310.1016/S0378-5173(98)00282-8 ↗
3. Domb AJ (1993) Lipospheres for controlled delivery of substances. United States Patent 5,188,837, 23 February 1993
4. Fängmark I, Carpin JC (1996) Protein nebulization. J Aerosol Sci 27:S231–S23210.1016/0021-8502(96)00188-7 ↗
5. Fillery-Travis AJ, Foster LH, Robins MM (1995) Stability of emulsions stabilised by two physiological surfactants: l-α-phosphatidylcholine and sodium taurocholate. Biophys Chem 54:253–26010.1016/0301-4622(94)00136-8 ↗
6. Fundarò A, Cavalli R, Bargoni A et al (2000) Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. Pharmacol Res 42:337–34310.1006/phrs.2000.0695 ↗
7. Gregoriadis G, McCormack B (eds) (1998) Targeting of drugs 6: strategies for stealth therapeutic systems. Plenum Press, New York
8. Kumpulainen JT, Salonen JT (eds) (1996) Natural antioxidants and food quality in atherosclerosis and cancer prevention. Royal Society of Chemistry, Cambridge
9. Mann JJ (1980) Antifungal agents. In: Postgraduate course in internal medicine; v. 6, prog. 1, no. 2. Johns Hopkins University, Baltimore
10. Mehnert W, Mäder K (2001) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47:165–19610.1016/S0169-409X(01)00105-3 ↗
11. Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur J Pharm Biopharm 50:161–17710.1016/S0939-6411(00)00087-4 ↗
12. Powell MF, Newman MJ (eds) (1995) Vaccine design: the subunit and adjuvant approach. Plenum Press, New York
13. Sato K, Garti N (1988) Crystallization and polymorphic transformation: an introduction. In: Sato K, Garti N (eds) Crystallization and polymorphism of fats and fatty acids. Marcel Dekker, New York
14. Schreier H (ed) (2001) Drug targeting technology: physical, chemical, biological methods. Marcel Dekker, New York
15. Siekmann B, Westesen K (1994) Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles. Colloids Surf B Biointerfaces 3:159–17510.1016/0927-7765(94)80063-4 ↗
16. Westesen K, Siekmann B (1997) Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles. Int J Pharm 151:35–4510.1016/S0378-5173(97)04890-4 ↗